JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases.

JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases.

The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK inhibitors in oral and topical formulations have shown beneficial results in psoriasis and alopecia areata. Patients suffering from other ISDs might a...

Full description

Bibliographic Details
Main Authors: Ana Karina Alves de Medeiros, Reinhart Speeckaert, Eline Desmet, Mireille Van Gele, Sofie De Schepper, Jo Lambert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5053514?pdf=render

Internet

http://europepmc.org/articles/PMC5053514?pdf=render

Similar Items